We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Templates of the Supplier Solution documentation to be used under the 2016 State aid decision
This section shows how to translate user needs into policy and services and how you to work collaboratively with users and specialists
The government's response to the Domestic Abuse Commissioner's report 'Safety Before Status: The Solutions'.
How we're identifying benefit fraud and the penalties people could face for deliberately withholding information for their benefit claim.
Report someone committing benefit fraud - you can report anonymously.
Steps SMEs can take when bidding for government contracts so they can compete with larger companies.
During Debt Awareness Week, we talk to Neil Sutton, a senior leader within the bankruptcy and Debt Relief Order teams at the Insolvency Service, about some of the options that can help people on their journey out of debt.
The Supplier Solution template(s) to be used as part of the invitation to tender documentation under BDUK’s 2016 State Aid Decision
Decision for applicant FXPro Financial Services Ltd registration number 14847581, applicant successful.
USV UK Limited has informed the MHRA that Sugammadex 100 mg/ml solution for injection (2 ml vial), batch number 35000347, may contain some vials that contain a low volume of solution; less than the label claim of 2 ml.
Sandoz has detected that information on the diluents in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) of cefuroxime contain incorrect information.
This Programme aims to achieve change in access to, purchase of, and use of smart energy technologies, products and services among low income and vulnerable consumers.
A list of local partners organisations that might be able to help reduce local vehicle crime, and the potential support they can provide.
Decision for applicant Oracle America, Inc. registration number 14465495, applicant successful.
Orifarm UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in one batch of Buccolam 10mg Oromucosal solution has missing information regarding having to break the seal on the inner container before use.
Systematic literature review reporting recommendations for safeguarding and protecting children.
Decision for applicant Capita Plc registration number OC448229, applicant successful.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.